LRRK2 and Parkinson disease: Although iPD and LRRK2 G2019S-PD patients are described as clinically and pathologically similar [2], some studies showed that LRRK2-PD patients may differ from iPD patients regarding growth factor concentrations and interleukin 8 (IL-8) levels in CSF [34].